The "Global Surface Guided Radiation Therapy (SGRT) Devices Market, By Device Type (Portable v/s Fixed), By Application (Breast Cancer, Head & Neck Cancer, Abdominal & Pelvic Cancer, Dermatology, Others), By End User, By Region, Competition Forecast & Opportunities, 2026" report

Image courtesy of Varian


September 24, 2021 — The "Global Surface Guided Radiation Therapy (SGRT) Devices Market, By Device Type (Portable v/s Fixed), By Application (Breast Cancer, Head & Neck Cancer, Abdominal & Pelvic Cancer, Dermatology, Others), By End User, By Region, Competition Forecast & Opportunities, 2026" report has been added to ResearchAndMarkets.com's offering.

Global surface guided radiation therapy (SGRT) devices market is projected to see an extraordinary growth in the forecast period, 2022-2026. The market growth can be attributed to the increasing instances of skin cancer. The advancing novel technology in radiotherapy for the cancer treatment is further substantiating the growth of the market. Moreover, increased adoption of radiotherapy devices and procedures along with the rising preference for the non-surgical procedures are further substantiating the growth of the global SGRT devices market in the upcoming five years.

In addition, the technological advancement in SGRT devices has advantages like patient positioning with real-time feedback, patient monitoring throughout the treatment fraction and motion management. More technical advancements including accelerated partial breast irradiation, particle radiotherapy, and pediatrics are also actively responsible for the growth of the global SGRT devices market in the next five years. However, the high cost of the therapy and the medical device may put a mild restraint on the global SGRT devices market growth in the future five years of forecast until 2026.

Surface guided radiation therapy devices are the medical radiation devices that are utilized for the SGRT. The technology positions and monitors the patient's surface radiation process on the external surface such that the patient's positioning is apt. This procedure provides transitional and rotational information of the patient's skin surface and offers the potential to improve the accuracy of setup. The global devices market segmentation is based on device type, application, end user, regional distribution, and competitional landscape. Based on device type, the market is divided between portable and fixed devices.

Fixed devices are anticipated to hold the largest revenue shares of the market and dominate the market segment on the account of increasing advancement in the healthcare industry dedicated toward oncological treatment and diagnostic processes. Portable devices are expected to register the fastest growing CAGR in the upcoming five years with its added advantage of mobility. These devices are more affordable, and can be installed in smaller healthcare centers, and clinics too, thereby supporting the growth of the global surface guided radiation therapy devices market in the next five years. Added advantages include emission of electrons, photons, and other fast-moving subatomic particles, and use of x-ray tubes to build contact between the device and the targeted area in patient's body.

Market players are actively involved in the research and technological development in the product developments. The advanced technology has made it possible for the industry to provide excellent services through SGRT devices. Further advancement would aid the market value and brand establishment in the future five years. New market players may focus on the research and development to provide options that satisfies the consumer demand as well as benefits the market players in building their brand value. Other competitive strategies include mergers and acquisitions and new product developments.

For more information: www.researchandmarkets.com/r/t666r5

Related Content

Feature | Radiology Business | By Melinda Taschetta-Millane

Did you know that Imaging Technology News (ITN) maintains more than 40 comparison charts of product specifications from ...

Time August 12, 2022
arrow
News | ASTRO

August 12, 2022 — The American Society for Radiation Oncology (ASTRO) today expressed its support for President Joseph R ...

Time August 12, 2022
arrow
News | Lung Imaging

August 10, 2022 — Mount Sinai is leading a team of lung cancer researchers that has been awarded a three-year, $500,000 ...

Time August 10, 2022
arrow
News | Prostate Cancer

August 9, 2022 — Bot Image, an Omaha-based MRI medical device company has developed an AI-driven medical device CAD ...

Time August 09, 2022
arrow
News | Breast Imaging

August 8, 2022 — The U.S. Food and Drug Administration approved Enhertu (fam-trastuzumab-deruxtecan-nxki), an IV ...

Time August 08, 2022
arrow
News | Lung Imaging

August 8, 2022 — Representatives from the Diagnostics Working Group of the IASLC Early Detection and Screening Committee ...

Time August 08, 2022
arrow
News | Lung Imaging

August 8, 2022 — A clinical trial is only as powerful as its participants. For years, researchers have struggled to fill ...

Time August 08, 2022
arrow
News | Proton Therapy

August 5, 2022 — IBA (Ion Beam Applications S.A., EURONEXT), a world leader in particle accelerator technology, Fred ...

Time August 05, 2022
arrow
News | Radiology Business

August 4, 2022 — The Biden Administration, through the U.S. Department of Health and Human Services and the Centers for ...

Time August 04, 2022
arrow
News | Pediatric Imaging

August 3, 2022 — The Jack Martin Fund (JMF) has built on its partnership with the Mount Sinai Health System to provide ...

Time August 03, 2022
arrow
Subscribe Now